Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial
Journal of Antimicrobial Chemotherapy (2021) - Comments
doi: 10.1093/jac/dkaa501  issn: 0305-7453  issn: 1460-2091  pubmed: 33338232 

Fatemeh Roozbeh, Majid Saeedi, Reza Alizadeh-Navaei, Akbar Hedayatizadeh-Omran, Shahin Merat, Hannah Wentzel, Jacob Levi, Andrew Hill, Amir Shamshirian